Cargando…
Dissecting mechanisms of resistance to targeted drug combination therapy in human colorectal cancer
Genomic alterations in cancer cells result in vulnerabilities that clinicians can exploit using molecularly targeted drugs, guided by knowledge of the tumour genotype. However, the selective activity of these drugs exerts an evolutionary pressure on cancers that can result in the outgrowth of resist...
Autores principales: | Clarke, Paul A., Roe, Toby, Swabey, Kate, Hobbs, Steve M., McAndrew, Craig, Tomlin, Kathy, Westwood, Isaac, Burke, Rosemary, van Montfort, Robert, Workman, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755994/ https://www.ncbi.nlm.nih.gov/pubmed/30905967 http://dx.doi.org/10.1038/s41388-019-0780-z |
Ejemplares similares
-
The discovery of potent ribosomal S6 kinase inhibitors by high-throughput screening and structure-guided drug design
por: Couty, Sylvain, et al.
Publicado: (2013) -
A fragment-based approach applied to a highly flexible target: Insights and challenges towards the inhibition of HSP70 isoforms
por: Jones, Alan M., et al.
Publicado: (2016) -
Exploiting Protein
Conformational Change to Optimize
Adenosine-Derived Inhibitors of HSP70
por: Cheeseman, Matthew D., et al.
Publicado: (2016) -
Fragment-Based Screening Maps Inhibitor Interactions in the ATP-Binding Site of Checkpoint Kinase 2
por: Silva-Santisteban, M. Cris, et al.
Publicado: (2013) -
Structure-based drug design: aiming for a perfect fit
por: van Montfort, Rob L.M., et al.
Publicado: (2017)